Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2016, Article ID 5178953, 7 pages
http://dx.doi.org/10.1155/2016/5178953
Research Article

X-Linked Adrenal Hypoplasia Congenita in a Boy due to a Novel Deletion of the Entire NR0B1 (DAX1) and MAGEB14 Genes

1Poznan University of Medical Sciences, 2nd Chair of Pediatrics, Department of Pediatric Endocrinology and Rheumatology, 27/33 Szpitalna Street, 60-572 Poznan, Poland
2Poznan University of Medical Sciences, Chair and Department of Medical Genetics, Rokietnicka 8 Street, 60-806 Poznan, Poland
3Center for Medical Genetics GENESIS, 4 Grudzieniec Street, Poznan, Poland
4Ludwik Rydygier’s Provincial Hospital in Torun, Children’s Hospital, Division of Pediatrics, Pediatric Endocrinology and Pediatric Neurology, 42 Konstytucji 3 Maja Street, 87-100 Torun, Poland
5The Children’s Memorial Health Institute, Department of Laboratory Diagnostics, 20 Al. Dzieci Polskich, 04-736 Warsaw, Poland
6Karol Jonscher’s Clinical Hospital, 27/33 Szpitalna Street, 60-572 Poznan, Poland

Received 31 May 2016; Accepted 26 July 2016

Academic Editor: Sabrina Corbetta

Copyright © 2016 Aleksandra Rojek et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Muscatelli, T. M. Strom, A. P. Walker et al., “Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism,” Nature, vol. 372, no. 6507, pp. 672–676, 1994. View at Publisher · View at Google Scholar · View at Scopus
  2. J. A. Bartley, S. Patil, S. Davenport, D. Goldstein, and J. Pickens, “Duchenne muscular dystrophy, glycerol kinase deficiency, and adrenal insufficiency associated with Xp21 interstitial deletion,” The Journal of Pediatrics, vol. 108, no. 2, pp. 189–192, 1986. View at Publisher · View at Google Scholar · View at Scopus
  3. D. E. C. Cole, L. A. Clarke, D. C. Riddell, K. A. Samson, W. K. Seltzer, and S. Salisbury, “Congenital adrenal hypoplasia, Duchenne muscular dystrophy, and glycerol kinase deficiency: importance of laboratory investigations in delineating a contiguous gene deletion syndrome,” Clinical Chemistry, vol. 40, no. 11, pp. 2099–2103, 1994. View at Google Scholar · View at Scopus
  4. L. Lin, W.-X. Gu, G. Ozisik et al., “Analysis of DAX1 (NR0B1) and steroidogenic factor-1 (NR5A1) in children and adults with primary adrenal failure: Ten years' experience,” The Journal of Clinical Endocrinology & Metabolism, vol. 91, no. 8, pp. 3048–3054, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. Y.-H. Zhang, B.-L. Huang, K. K. Niakan, L. L. McCabe, E. R. B. McCabe, and K. M. Dipple, “IL1RAPL1 is associated with mental retardation in patients with complex glycerol kinase deficiency who have deletions extending telomeric of DAX1,” Human Mutation, vol. 24, no. 3, p. 273, 2004. View at Google Scholar · View at Scopus
  6. J.-H. Choi, Y.-L. Shin, G.-H. Kim et al., “Identification of novel mutations of the DAX-1 gene in patients with X-linked adrenal hypoplasia congenita,” Hormone Research, vol. 63, no. 4, pp. 200–205, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Zanaria, F. Muscatelli, B. Bardoni et al., “An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita,” Nature, vol. 372, no. 6507, pp. 635–641, 1994. View at Publisher · View at Google Scholar · View at Scopus
  8. A. K. Iyer and E. R. B. McCabe, “Molecular mechanisms of DAX1 action,” Molecular Genetics and Metabolism, vol. 83, no. 1-2, pp. 60–73, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Lalli, K. Ohe, C. Hindelang, and P. Sassone-Corsi, “Orphan receptor DAX-1 is a shuttling RNA binding protein associated with polyribosomes via mRNA,” Molecular and Cellular Biology, vol. 20, no. 13, pp. 4910–4921, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. http://www.hgmd.org.
  11. J. C. Achermann, B. L. Silverman, R. L. Habiby, and J. L. Jameson, “Presymptomatic diagnosis of X-linked adrenal hypoplasia congenita by analysis of DAX1,” Journal of Pediatrics, vol. 137, no. 6, pp. 878–881, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. J. C. Achermann, M. Ito, B. L. Silverman et al., “Missense mutations cluster within the carboxyl-terminal region of DAX-1 and impair transcriptional repression,” The Journal of Clinical Endocrinology & Metabolism, vol. 86, no. 7, pp. 3171–3175, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Nakae, S. Abe, T. Tajima et al., “Three novel mutations and a De novo deletion mutation of the DAX-1 gene in patients with X-linked adrenal hypoplasia congenita,” Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 11, pp. 3835–3841, 1997. View at Publisher · View at Google Scholar · View at Scopus
  14. A. T. Reutens, J. C. Achermann, M. Ito et al., “Clinical and functional effects of mutations in the DAX-1 gene in patients with adrenal hypoplasia congenita,” Journal of Clinical Endocrinology and Metabolism, vol. 84, no. 2, pp. 504–511, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Wiltshire, J. Couper, C. Rodda, L. Jameson, and J. C. Achermann, “Variable presentation of X-linked adrenal hypoplasia congenita,” Journal of Pediatric Endocrinology and Metabolism, vol. 14, no. 8, pp. 1093–1096, 2001. View at Google Scholar · View at Scopus
  16. A. A. Verrijn Stuart, G. Ozisik, M. A. De Vroede et al., “Clinical case seminar: an amino-terminal DAX1 (NROB1) missense mutation associated with isolated mineralocorticoid deficiency,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 3, pp. 755–761, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Krude, H. Biebermann, W. Luck, R. Horn, G. Brabant, and A. Grüters, “Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans,” Nature Genetics, vol. 19, no. 2, pp. 155–157, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Vaidya, S. Pearce, and P. Kendall-Taylor, “Recent advances in the molecular genetics of congenital and acquired primary adrenocortical failure,” Clinical Endocrinology, vol. 53, no. 4, pp. 403–418, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Peter, M. Viemann, C.-J. Partsch, and W. G. Sippell, “Congenital adrenal hypoplasia: clinical spectrum, experience with hormonal diagnosis, and report on new point mutations of the DAX-1 gene,” The Journal of Clinical Endocrinology & Metabolism, vol. 83, no. 8, pp. 2666–2674, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Domenice, A. C. Latronico, V. N. Brito, I. J. P. Arnhold, F. Kok, and B. B. Mendonca, “Clinical case seminar: adrenocorticotropin-dependent precocious puberty of testicular origin in a boy with X-linked adrenal hypoplasia congenita due to a novel mutation in the DAX1 gene,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 9, pp. 4068–4071, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. K.-Y. Loke, L. K.-S. Poh, W. W.-R. Lee, and P.-S. Lai, “A case of X-linked adrenal hypoplasia congenita, central precocious puberty and absence of the DAX-1 gene: implications for pubertal regulation,” Hormone Research, vol. 71, no. 5, pp. 298–304, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Darcan, D. Goksen, S. Ozen, F. Ozkinay, B. Durmaz, and E. Lalli, “Gonadotropin-dependent precocious puberty in a patient with X-linked adrenal hypoplasia congenita caused by a novel DAX-1 mutation,” Hormone Research in Paediatrics, vol. 75, no. 2, pp. 153–156, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. R. L. Habiby, P. Boepple, L. Nachtigall, P. M. Sluss, W. F. Crowley Jr., and J. L. Jameson, “Adrenal hypoplasia congenita with hypogonadotropic hypogonadism: evidence that DAX-1 mutations lead to combined hypothalamic and pituitary defects in gonadotropin production,” The Journal of Clinical Investigation, vol. 98, no. 4, pp. 1055–1062, 1996. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Tabarin, J. C. Achermann, D. Recan et al., “A novel mutation in DAX1 causes delayed-onset adrenal insufficiency and incomplete hypogonadotropic hypogonadism,” The Journal of Clinical Investigation, vol. 105, no. 3, pp. 321–328, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Bardoni, E. Zanaria, S. Guioli et al., “A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal,” Nature Genetics, vol. 7, no. 4, pp. 497–501, 1994. View at Publisher · View at Google Scholar · View at Scopus
  26. T. L. Born, D. E. Smith, K. E. Garka et al., “Identification and characterization of two members of a novel class of the interleukin-1 receptor (IL-1R) family. delineation of a new class of IL-1R-related proteins based on signaling,” The Journal of Biological Chemistry, vol. 275, pp. 29946–29954, 2000. View at Google Scholar
  27. T. Boon and B. J. Van den Eynde, “Shared tumor-specific antigens,” in Principles and Practice of the Biologic Treatment of Cancer, S. A. Rosenberg, Ed., pp. 493–504, Lippincott Williams and Wilkins, Philadelphia, Pa, USA, 3rd edition, 2000. View at Google Scholar
  28. G. Ozisik, G. Mantovani, J. C. Achermann et al., “An alternate translation initiation site circumvents an amino-terminal DAX1 nonsense mutation leading to a mild form of X-linked adrenal hypoplasia congenita,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 1, pp. 417–423, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. K. K. Niakan and E. R. B. McCabe, “DAX1 origin, function, and novel role,” Molecular Genetics and Metabolism, vol. 86, no. 1-2, pp. 70–83, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Ho, Y.-H. Zhang, B.-L. Huang, and E. R. B. McCabe, “NR0B1A: an alternatively spliced form of NR0B1,” Molecular Genetics and Metabolism, vol. 83, no. 4, pp. 330–336, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Chomez, O. De Backer, M. Bertrand, E. De Plaen, T. Boon, and S. Lucas, “An overview of the MAGE gene family with the identification of all human members of the family,” Cancer Research, vol. 61, no. 14, pp. 5544–5551, 2001. View at Google Scholar
  32. A. Rojek, M. Flader, E. Malecka, and M. Niedziela, “A novel mutation in the NR0B1 (DAX1) gene in a large family with two boys affected by congenital adrenal hypoplasia,” Hormones, vol. 13, no. 3, pp. 413–419, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Rojek, M. Obara-Moszynska, E. Malecka, M. Slomko-Jozwiak, and M. Niedziela, “NR0B1 (DAX1) mutations in patients affected by congenital adrenal hypoplasia with growth hormone deficiency as a new finding,” Journal of Applied Genetics, vol. 54, no. 2, pp. 225–230, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. M. G. Shaikh, L. Boyes, H. Kingston et al., “Skewed X inactivation is associated with phenotype in a female with adrenal hypoplasia congenita,” Journal of Medical Genetics, vol. 45, no. 9, article e1, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. T. Suzuki, M. Kasahara, H. Yoshioka, K.-I. Morohashi, and K. Umesono, “LXXLL-related motifs in Dax-1 have target specificity for the orphan nuclear receptors Ad4BP/SF-1 and LRH-1,” Molecular and Cellular Biology, vol. 23, no. 1, pp. 238–249, 2003. View at Publisher · View at Google Scholar · View at Scopus